Cellular delivery of noncovalently-associated macromolecules by cell-penetrating peptides

Current Pharmaceutical Biotechnology

Volumn 15, Issue 3, 2014, Pages 267-275

  Chang, Microsugar ^a   Huang, Yue Wern ^b   Aronstam, Robert S ^b   Lee, Han Jung ^c  

^a HUNGKUANG UNIVERSITY   (Taiwan)

^b MISSOURI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (United States)

^c NATIONAL DONG HWA UNIVERSITY   (Taiwan)

Author keywords

Cell penetrating peptide; Cellular internalization; Macropinocytosis; Polyarginine; Protein transduction domain; Quantum dots

Indexed keywords

CELL PENETRATING PEPTIDE; QUANTUM DOT; DNA; NANOMATERIAL; PROTEIN; RNA; BETA GALACTOSIDASE; DRUG CARRIER; ENHANCED GREEN FLUORESCENT PROTEIN; NANOPARTICLE; PROTEOHEPARAN SULFATE; RED FLUORESCENT PROTEIN; SMALL INTERFERING RNA; SULFORHODAMINE B;

ARTICLE; COVALENT BOND; DNA IMMUNIZATION; DRUG DELIVERY SYSTEM; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE THERAPY; INTERNALIZATION; MACROMOLECULE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PINOCYTOSIS; RNA INTERFERENCE; ANIMAL; CHEMISTRY; HUMAN; TRANSPORT AT THE CELLULAR LEVEL; BIOCOMPATIBILITY; CELL MEMBRANE TRANSPORT; CONFOCAL MICROSCOPY; CYTOTOXICITY; DRUG DELIVERY DEVICE; DRUG PENETRATION; DRUG PROTEIN BINDING; DRUG TRANSPORT; FLOW CYTOMETRY; PROTEIN TRANSDUCTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RNA METABOLISM;

ANIMALS; BIOLOGICAL TRANSPORT; CELL-PENETRATING PEPTIDES; DNA; DRUG DELIVERY SYSTEMS; HUMANS; NANOSTRUCTURES; PROTEINS; RNA;

EID: 84907362083     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201015666140617095415     Document Type: Article

References (89)

1. Wang, W.; Li, W.; Ma, N.; Steinholl, G. Non-viral gene delivery methods. Curr. Pharm. Biotechnol., 2013, 14(1), 46-60.
2. Fonseca, S.B.; Pereira, M.P.; Kelley, S.O. Recent advances in the use of cell-penetrating peptides for medical and biological applications. Adv. Drug Deliv. Rev., 2009, 61(11), 953-964.
3. Kilk, K.; Mahlapuu, R.; Soomets, U.; Langel, U. Analysis of in vitro toxicity of five cell-penetrating peptides by metabolic profiling. Toxicol., 2009, 265(3), 87-95.
4. Snyder, E.L.; Dowdy, S.F. Cell penetrating peptides in drug delivery. Pharm. Res., 2004, 21(3), 389-393.
5. Huang Y.; Jiang, Y.; Wang, H.; Wang, J.; Shin, M.C.; Byun, Y.; He, H.; Liang, Y.; Yang, V.C. Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery. Adv. Drug Deliv. Rev., 2013, 65(10), 1299-1315.
6. Wang, F.; Wang, Y.; Zhang, X.; Zhang, W.; Guo, S.; Jin, F. Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery. J. Control. Release, 2014, 174(C), 126-136.
7. Green, M.; Loewenstein, P. Autonomous functional domains of chemically synthesized human immunodeficiency virus Tat transactivator protein. Cell, 1988, 55(6), 1179-1188.
8. Frankel, A.; Pabo, C. Cellular uptake of the Tat protein from human immunodeficiency virus. Cell, 1988, 55(6), 1189-1193.
9. Vives, E.; Brodin, P.; Lebleu, B. A truncated HIV-1 tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem., 1997, 272(25), 16010-16017.
10. Wadia, J.S.; Dowdy, S.F. Protein transduction technology. Curr. Opin. Biotechnol., 2002, 13(1), 52-56.
11. De Coupade, C.; Fittipaldi, A.; Chagnas, V.; Michel, M.; Carlier, S.; Tasciotti, E.; Darmon, A.; Ravel, D.; Kearsey, J.; Giacca, M.; Cailler, F. Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules. Biochem J., 2005, 390(2), 407-418.
12. Regberg, J.; Srimanee, A.; Erlandsson, M.; Sillard, R.; Dobchev, D.A.; Karelson, M.; Langel, U. Rational design of a series of novel amphipathic cell-penetrating peptides. Int. J. Pharm., 2014, 464(1- 2), 111-116.
13. Futaki, S.; Suzuki, T.; Ohashi, W.; Yagami, T.; Tanaka, S.; Ueda, K.; Sugiura, Y. Arginine-rich peptides. J. Biol. Chem., 2001, 276(8), 5836-5840.
14. Guterstam, P.; Madani, F.; Hirose, H.; Takeuchi, T.; Futaki, S.; El- Andaloussi, S.; Graslund, A.; Langel, U. Elucidating cellpenetrating peptide mechanisms of action for membrane interaction, cellular uptake, and translocation utilizing the hydrophobic counter-anion pyrenebutyrate. Biochim. Biophys. Acta, 2009, 1788(12), 2509-2517.
15. Gautam, A.; Singh, H.; Tyagi, A.; Chaudhary, K.; Kumar, R.; Kapoor, P.; Raghava, G.P. CPPsite: A curated database of cell penetrating peptides. Database, 2012, 2012, bas015.
16. Holton, T.A.; Pollastri, G.; Shields, D.C.; Mooney, C. CPPpred: prediction of cell penetrating peptides. Bioinformatics, 2013, 29(23), 3094-3096.
17. Gauram, A.; Chaudhary, K.; Kumar, R.; Sharma, A.; Kapoor, P.; Tyagi, A.; Open source drug discovery consortium, Raghava, G.P. In silico approaches for designing highly effective cell penetrating peptides. J. Transl. Med., 2013, 11, 74.
18. Margus, H.; Padari, K.; Pooga, M. Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery. Mol. Ther., 2012, 20(3), 525-533.
19. Mae, M.; Andaloussi, S.E.; Lehto, T.; Langel, U. Chemically modified cell-penetrating peptides for the delivery of nucleic acids. Expert Opin. Drug Deliv., 2009, 6(11), 1195-1205.
20. Wu, G.Y.; Wu, C.H. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem., 1987, 262(10), 4429-4432.
21. Lindgren, M.; Hallbrink, M.; Prochiantz, A.; Langel, U. Cellpenetrating peptides. Trends Pharmacol. Sci., 2000, 21(3), 99-103.
22. Dowdy, S.F.; Snyder, E.L. Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo. Expert Opin. Drug Deliv., 2005, 2(1), 43-51.
23. Chen, C.P.; Chou, J.C.; Liu, B.R.; Chang, M.; Lee, H.J. Transfection and expression of plasmid DNAin plant cellsbyan arginine-rich intracellular delivery peptide without protoplast preparation. FEBS Lett., 2007, 581(9), 1891-1897.
24. Li, J.F.; Huang, Y.; Chen, R.L.; Lee, H.J. Induction of apoptosis bygene transfer of human TRAIL mediated by arginine-rich intracellular delivery peptides. Anticancer Res., 2010, 30(6), 2193-2202.
25. Lee, C.Y.; Li, J.F.; Liou, J.S.; Charng, Y.C.; Huang, Y.W.; Lee, H.J. A gene delivery system for human cells mediated by both a cell-penetrating peptide and a piggy Bac transposase. Biomaterials, 2011, 32(26), 6264-6276.
26. Dai, Y.H.; Liu, B.R.; Chiang, H.J; Lee, H.J. Gene transport and expression by arginine-rich cell-penetrating peptides in Paramecium. Gene, 2011, 489(2), 89-97.
27. Chen, Y.J.; Liu, B.R.; Dai, Y.H.; Lee, C.Y.; Chan, M.H.; Chen, H.H.; Chiang, H.J.; Lee, H.J. A gene delivery system for insect cells mediated by arginine-rich cell-penetrating peptides. Gene, 2012, 493(2), 201-210.
28. Liu, B.R.; Lin, M.D.; Chiang, H.J.; Lee, H.J. Arginine-rich cellpenetrating peptidesdelivergene into living human cells. Gene, 2012, 505(1), 37-45.
29. Liu, M.J.; Chou, J.C; Lee, H.J. A gene delivery method mediated by threearginine-rich cell-penetrating peptides in plant cells. Adv. Stud. Biol., 2013, 5(2), 71-88.
30. Liu, B.R.; Liou, J.S.; Chen, Y.J.; Huang, Y.W.; Lee, H.J. Delivery of nucleic acids, proteins, and nanoparticles by arginine-rich cellpenetrating peptides in rotifers. Mar. Biotechnol., 2013, 15(5), 584-595.
31. Liu, B.R.; Liou, J.S.; Huang, Y.W.; Aronstam, R.S.; Lee, H.J. Intracellular delivery of nanoparticles and DNAs by IR9 cellpenetrating peptides. PLoS One, 2013, 8(5), e64205.
32. Liu, B.R.; Huang, Y.W.; Chiang, H.J; Lee, H.J. Primary effectors in the mechanisms of transmembrane delivery of arginine-rich cellpenetrating peptides. Adv. Stud. Biol., 2013, 5(1), 11-25.
33. Meade, B.R.; Dowdy, S.F. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides. Adv. Drug Deliv. Rev., 2007, 59(2-3), 134-140.
34. Simeoni, F.; Morris, M.C.; Heitz, F.; Divita, G. Insight into the mechanism of peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucl. Acids Res., 2003, 31(11), 2717-2724.
35. Unnamalai, N.; Kang, B.G.; Lee, W.S. Cationic oligopeptidemediated delivery of dsRNA for post-transcriptional gene silencing in plant cells. FEBS Lett., 2004, 566(1-3), 307-310.
36. Wang, Y.H.; Hou, Y.W.; Lee, H.J. An intracellular delivery method for siRNA by an arginine-rich peptide. J. Biochem. Biophys. Methods, 2007, 70(4), 579-586.
37. Trabulo, S.; Cardoso, A.L.; Mano, M.; Pedroso de Lima, M.C. Cell-penetrating peptides-mechanisms of cellular uptake and generation of delivery systems. Pharmaceuticals, 2010, 3(4), 961-993.
38. Schwarze, S.R.; Ho, A.; Vocero-Akbani, A.; Dowdy, S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science, 1999, 285(5433), 1569-1572.
39. Chang, M.; Chou, J.C.; Lee, H.J. Cellular internalization of fluorescent proteins via arginine-rich intracellular delivery peptide in plant cells. Plant Cell Physiol., 2005, 46(3), 482-488.
40. Liu, K.; Lee, H.J.; Leong, S.S.; Liu, C.L.; Chou, J.C. A bacterial indole-3-acetyl-L-aspartic acid hydrolase inhibits mungbean (Vigna radiata L.) seed germination through arginine-rich intracellular delivery. J. Plant Growth Regul., 2007, 26(3), 278-284.
41. Liou, J.S.; Liu, B.R.; Martin, A.L.; Huang, Y.W.; Chiang, H.J.; Lee, H.J. Protein transduction in human cells is enhanced by cellpenetrating peptides fused with an endosomolyticHA2 sequence. Peptides, 2012, 37(2), 273-284.
42. Wang, Y.H.; Chen, C.P.; Chan, M.H.; Chang, M.; Hou, Y.W.; Chen, H.H.; Hsu, H.R.; Liu, K.; Lee, H.J. Arginine-rich intracellular delivery peptides noncovalently transport protein into living cells. Biochem. Biophys. Res. Commun., 2006, 346(3), 758-767.
43. Liu, B.R.; Huang, Y.W.; Lee, H.J. Mechanistic studies of intracellular delivery of proteins by cell-penetrating peptides in cyanobacteria. BMC Microbiol., 2013, 13, 57.
44. Chang, M.; Chou, J.C.; Chen, C.P.; Liu, B.R.; Lee, H.J. Noncovalent protein transductionin plant cells by macropinocytosis. New Phytol., 2007, 174(1), 46-56.
45. Hou, Y.W.; Chan, M.H.; Hsu, H.R.; Liu, B.R.; Chen, C.P.; Chen, H.H.; Lee, H.J. Transdermal delivery of proteins mediated by noncovalently associated arginine-rich intracellular delivery peptides. Exp. Dermatol., 2007, 16(12), 999-1006.
46. Liu, B.R.; Chou, J.C.; Lee, H.J. Cell membrane diversity in noncovalent protein transduction. J. Membr. Biol., 2008, 222(1), 1-15.
47. Hu, J.W.; Liu, B.R.; Wu, C.Y.; Lu, S.W.; Lee, H.J. Protein transport in human cells mediated by covalently and noncovalently conjugated arginine-rich intracellular delivery peptides. Peptides, 2009, 30(9), 1669-1678.
48. Lu, S.W.; Hu, J.W.; Liu, B.R.; Lee, C.Y.; Li, J.F.; Chou, J.C.; Lee, H.J. Arginine-rich intracellular delivery peptides synchronously deliver covalently and noncovalently linked proteins intoplant cells. J. Agricult. Food Chem., 2010, 58(4), 2288-2294.
49. Stephens, D.J.; Allan, V.J. Light microscopy techniques for live cell imaging. Science, 2003, 300(5616), 82-86.
50. Michalet, X.; Pinaud, F.F.; Bentolila, L.A.; Tsay, J.M.; Doose, S.; Li, J.J.; Sundaresan, G.; Wu, A.M.; Gambhir, S.S.; Weiss, S. Quantum dots for live cells, in vivo imaging, and diagnostics. Science, 2005, 307(5709), 538-544.
51. Shin, M.C.; Zhang, J.; Min, K.A.; Lee, K.; Byun, Y.; David, A.E.; He, H.; Yang, V.C. Cell-penetrating peptides: Achievements and challenges in application for cancer treatment. J. Biomed. Mater. Res. A, 2014, 102(2), 575-587.
52. Josephson, L.; Tung, C.H.; Moore, A.; Weissleder, R. Highefficiency intracellular magnetic labeling with novel superparamagnetic- Tat peptide conjugates. Bioconjug. Chem., 1999, 10(2), 186-191.
53. Stroh, M.; Zimmer, J.P.; Duda, D.G.; Levchenko, T.S.; Cohen, K.S.; Brown, E.B.; Scadden, D.T.; Torchilin, V.P.; Bawendi, M.G.; Fukumura, D.; Jain, R.K. Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo. Nat. Med., 2005, 11(6), 678-682.
54. Torhilin, V.P.; Levchenko, T.S.; Rammohan, R.; Volodina, N.; Papahadjopoulos-Sternberg, B.; D'Souza, G.G. Cell transfection in vitro and in vivo with nontoxic Tat peptide-liposome-DNA complexes. Proc. Natl. Acad. Sci. USA, 2003, 100(4), 1972-1977.
55. Liu, B.R.; Li, J.F.; Lu, S.W.; Lee, H.J.; Huang, Y.W.; Shannon, K.B.; Aronstam, R.S. Cellular internalization of quantum dots noncovalently conjugated with arginine-rich cell-penetrating peptides. J. Nanosci. Nanotechnol., 2010, 10(10), 6534-6543.
56. Liu, B.R.; Huang, Y.W.; Chiang, H.J.; Lee, H.J. Cell-penetrating peptide-functionized quantum dots for intracellular delivery. J. Nanosci. Nanotechnol., 2010, 10(12), 7897-7905.
57. Xu, Y.; Liu, B.R.; Lee, H.J.; Shannon, K.B.; Winiarz, J.G.; Wang, T.C.; Chiang, H.J.; Huang, Y.W. Nona-arginine facilitates delivery of quantum dots into cells via multiple pathways. J. Biomed. Biotechnol., 2010, 2010, 948543.
58. Liu, B.R.; Huang, Y.W.; Winiarz, J.G.; Chiang, H.J.; Lee, H.J. Intracellular delivery of quantum dots mediated by a histidine- and arginine-rich HR9 cell-penetrating peptide through the direct membrane translocation mechanism. Biomaterials, 2011, 32(13), 3520-3537.
59. Liu, B.R.; Chiang, H.J.; Huang, Y.W.; Chan, M.H.; Chen, H.H.; Lee, H.J. Cellular internalization of quantum dots mediated by cellpenetrating peptides. Pharma. Nanotechnol., 2013, 1(2), 151-161.
60. Huang, Y.W.; Lee, H.J.; Liu, B.R.; Chiang, H.J.; Wu, C.H. Cellular internalization of quantum dots. Methods Mol. Biol., 2013, 991, 249-259.
61. Liu, B.R.; Lo, S.Y.; Liu, C.C.; Chyan, C.L.; Huang, Y.W.; Aronstam, R.S.; Lee, H.J. Endocytic trafficking of nanoparticles delivered by cell-penetrating peptides comprised of nano-arginine and a penetration accelerating sequence. PLoS One, 2013, 8(6), e67100.
62. Liu, B.R.; Winiarz, J.G.; Moon, J.S.; Lo, S.Y.; Huang, Y.W.; Aronstam, R.S.; Lee, H.J. Synthesis, characterization and applications of carboxylated and polyethylene-glycolated bifunctionalized InP/ZnSquantum dots in cellular internalization mediated by cellpenetrating peptides. Colloids Surf. B Biointerfaces, 2013, 111(C), 162-170.
63. Liu, B.R.; Chen, H.H.; Chan, M.H.; Huang, Y.W.; Aronstam, R.S.; Lee, H.J. Three arginine-rich cell-penetrating peptides facilitate cellular internalization of red-emitting quantum dots. J. Nanosci. Nanotechnol., 2014, in press.
64. Nath, A.; Psooy, K.; Martin, C.; Knudsen, B.; Magnuson, D.S.; Haughey, N.; Geiger, J.D. Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J. Virol., 1996, 70(3), 1475-1480.
65. Futaki, S. Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. Int. J. Pharm., 2002, 245(1-2), 1-7.
66. Ziegler, A.; Nervi, P.; Durrenberger, M.; Seelig, J. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence. Biochemistry, 2005, 44(1), 138-148.
67. Favretto, M.E.; Wallbrecher, R.; Schmidt, S.; van de Putte, R.; Brock, R. Glycosaminoglycans in the cellular uptake of drug delivery vectors-bystanders or active players? J. Control. Release, 2014, in press.
68. Lindsay, M.A. Peptide-mediated cell delivery: application in protein target validation. Curr. Opin. Pharmacol., 2002, 2(5), 587-594.
69. Rothbard, J.B.; Kreider, E.; VanDeusen, C.L.; Wright, L.; Wylite, B.L.; Wender, P.A. Arginine-rich molecular transporters for drug delivery: Role of backbone spacing in cellular uptake. J. Med. Chem., 2002, 45(17), 3612-3618.
70. Nakase, I.; Takeuchi, T.; Tanaka, G.; Futaki, S. Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides. Adv. Drug Deliv. Rev., 2008, 60(4-5), 598-607.
71. Wadia, J.S.; Stan, R.V.; Dowdy, S.F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med., 2004, 10(3), 310-315.
72. Conner, S.D.; Schmid, S.L. Regulated portals of entry into the cell. Nature, 2003, 422(6927), 37-44.
73. Kim, D.; Jeon, C.; Kim, J.H.; Kim, M.S.; Yoon, C.H.; Choi, I.S.; Kim, S.H.; Bae, Y.S. Cytoplasmic transduction peptide (CTP): new approach for the delivery of biomolecules into cytoplasm in vitro and in vivo. Exp. Cell Res., 2006, 312(8), 1277-1288.
74. Shokolenko, I.N.; Alexeyev, M.F.; LeDoux, S.P.; Wilson, G.L. TAT-mediated protein transduction and targeted delivery of fusion proteins into mitochondria of breast cancer cells. DNA Repair, 2005, 4(4), 511-518.
75. Melikov, K.; Chernomordik, L.V. Arginine-rich cell penetrating peptides: from endosomal uptake to nuclear delivery. Cell. Mol. Life Sci., 2005, 62(23), 2739-2749.
76. El-Sayed, A.; Futaki, S.; Harashima, H. Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment. AAPS J., 2009, 11(1), 13-22.
77. Herce, H.D.; Garcia, A.E.; Litt, J.; Kane, R.S.; Martin, P.; Enrique, N.; Rebolledo, A.; Milesi, V. Arginine-rich peptides destabilize the plasma membrane, consistent with a pore formation translocation mechanism of cell-penetrating peptides. Biophy. J., 2009, 97(7), 1917-1925.
78. Ter-Avetisyan, G.; Tunnemann, G.; Nowak, D.; Nitschke, M.; Herrmann, A.; Drab, M.; Cardoso, M.C. Cell entry of arginine-rich peptides is independent of endocytosis. J. Biol. Chem., 2009, 284(6), 3370-3378.
79. Schmidt, N.; Mishra, A.; Lai, G.H.; Wong, G.C. Arginine-rich cellpenetrating peptides. FEBS Lett., 2009, 584(9), 1806-1813.
80. Reuter, M.; Schwieger, C.; Meister, A.; Karlsson, G.; Blume, A. Poly-L-lysines and poly-L-arginines induce leakage of negatively charged phospholipid vesicles and translocate through the lipid bilayer upon electrostatic binding to the membrane. Biophy. Chem., 2009, 144(1-2), 27-37.
81. Chauhan, A.; Tikoo, A.; Kapur, A.K.; Singh, M. The taming of the cell penetrating domain of the HIV Tat: myths and realities. J. Control. Release, 2007, 117(2), 148-162.
82. Karagiannis, E.D.; Urbanska, A.M.; Sahay, G.; Pleet, J.M.; Jhunjhunwala, S.; Langer, R.; Anderson, D.G. Rational design of a biomimetic cell penetrating peptide library. ACS Nano, 2013, 7(10), 8616-8626.
83. Magzoub, M.; Sandgren, S.; Lundberg, P.; Oglecka, K.; Lilja, J.; Wittrup, A.; Goran Eriksson, L.E.; Langel, U.; Belting, M.; Graslund, A. N-terminal peptides from unprocessed prion proteins enter cells by macropinocytosis. Biochem. Biophys. Res. Commun., 2006, 348(2), 379-385.
84. Chen, J.; Li, G.; Lu, J.; Chen, L.; Huang, Y.; Wu, H.; Zhang, J.; Lu, D. A novel type of PTD, common helix-loop-helix motif, could efficiently mediate protein transduction into mammalian cells. Biochem. Biophys. Res. Commun., 2006, 347(4), 931-940.
85. Nomura, T.; Kawamura, M.; Shibata, H.; Abe, Y.; Ohkawa, A.; Mukai, Y.; Sugita, T.; Nagano, K.; Okamoto, T.; Tsutsumi, T.; Kamada, H.; Nakagawa, S.; Tsunoda, S. Creation of a novel cellpenetrating peptide, using a random 18mer peptides library. Pharmazie, 2007, 62(8), 569-573.
86. Kamide, K.; Nakakubo, H.; Uno, S.; Fukamizu, A. Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications. Int. J. Mol. Med., 2009, 25(1), 41-51.
87. Goda, N.; Tenno, T.; Inomata, K.; Iwaya, N.; Sasaki, Y.; Shirakawa, M.; Hiroaki, H. LBT/PTD dual tagged vector for purification, cellular protein delivery and visualization in living cells. Biochim. Biophys. Acta, 2007, 1773(2), 141-146.
88. Aubry, S.; Aussedat, B.; Delaroche, D.; Jiao, C.Y.; Bolbach, G.; Lavielle, S.; Chassaing G.; Sagan, S.; Burlina, F. MALDI-TOF mass spectrometry: A powerful tool to study the internalization of cell-penetrating peptides. Biochim. Biophys. Acta, 2010, 1798(12), 2182-2189.
89. Gump, J.M.; June, R.K.; Dowdy, S.F. Revised role of glycosaminoglycans in TAT PTD-mediated cellular transduction. J. Biol. Chem., 2010, 285(2), 1500-1507.